123 related articles for article (PubMed ID: 38908062)
21. Boosting Reactive Oxygen Species Generation with a Dual-Catalytic Nanomedicine for Enhanced Tumor Nanocatalytic Therapy.
Su G; Xu H; Zhou F; Gong X; Tan S; He Y
ACS Appl Mater Interfaces; 2023 Dec; 15(51):59175-59188. PubMed ID: 38095444
[TBL] [Abstract][Full Text] [Related]
22. Disulfiram loaded calcium phosphate nanoparticles for enhanced cancer immunotherapy.
Li Q; Chao Y; Liu B; Xiao Z; Yang Z; Wu Y; Liu Z
Biomaterials; 2022 Dec; 291():121880. PubMed ID: 36334355
[TBL] [Abstract][Full Text] [Related]
23. Disulfiram-loaded metal organic framework for precision cancer treatment via ultrasensitive tumor microenvironment-responsive copper chelation and radical generation.
Zhang H; Zhang Q; Guo Z; Liang K; Boyer C; Liu J; Zheng Z; Amal R; Yun SLJ; Gu Z
J Colloid Interface Sci; 2022 Jun; 615():517-526. PubMed ID: 35152072
[TBL] [Abstract][Full Text] [Related]
24. Disulfiram anti-cancer efficacy without copper overload is enhanced by extracellular H2O2 generation: antagonism by tetrathiomolybdate.
Calderon-Aparicio A; Strasberg-Rieber M; Rieber M
Oncotarget; 2015 Oct; 6(30):29771-81. PubMed ID: 26356671
[TBL] [Abstract][Full Text] [Related]
25. H
Tang Z; Jiang S; Tang W; He Q; Wei H; Jin C; Wang S; Zhang H
Mol Pharm; 2023 Mar; 20(3):1717-1728. PubMed ID: 36809003
[TBL] [Abstract][Full Text] [Related]
26. Apoferritin as a Carrier of Cu(II) Diethyldithiocarbamate and Biomedical Application for Glutathione-Responsive Combination Chemotherapy.
Li X; Du K; Sun J; Feng F
ACS Appl Bio Mater; 2020 Jan; 3(1):654-663. PubMed ID: 35019410
[TBL] [Abstract][Full Text] [Related]
27. A disulfiram/copper gluconate co-loaded bi-layered long-term drug delivery system for intraperitoneal treatment of peritoneal carcinomatosis.
Wang P; Luo Q; Zhang L; Qu X; Che X; Cai S; Liu Y
Colloids Surf B Biointerfaces; 2023 Nov; 231():113558. PubMed ID: 37776774
[TBL] [Abstract][Full Text] [Related]
28. Nanomedicine Enables Drug-Potency Activation with Tumor Sensitivity and Hyperthermia Synergy in the Second Near-Infrared Biowindow.
Liu W; Xiang H; Tan M; Chen Q; Jiang Q; Yang L; Cao Y; Wang Z; Ran H; Chen Y
ACS Nano; 2021 Apr; 15(4):6457-6470. PubMed ID: 33750100
[TBL] [Abstract][Full Text] [Related]
29. Advancing Cancer Therapy with Copper/Disulfiram Nanomedicines and Drug Delivery Systems.
Kang X; Jadhav S; Annaji M; Huang CH; Amin R; Shen J; Ashby CR; Tiwari AK; Babu RJ; Chen P
Pharmaceutics; 2023 May; 15(6):. PubMed ID: 37376016
[TBL] [Abstract][Full Text] [Related]
30. The disulfiram/copper complex induces apoptosis and inhibits tumour growth in human osteosarcoma by activating the ROS/JNK signalling pathway.
Guo W; Zhang X; Lin L; Wang H; He E; Wang G; Zhao Q
J Biochem; 2021 Oct; 170(2):275-287. PubMed ID: 33792698
[TBL] [Abstract][Full Text] [Related]
31. Orchestrating Precision within the Tumor Microenvironment by Biomimetic Nanoprodrugs for Effective Tumor Therapy.
Wang Y; Xu H; Huang X; Zhang Y; Lu Y; Cheng J; Xu X; Li J; Yao H; Chen X
ACS Appl Mater Interfaces; 2024 Feb; 16(7):8484-8498. PubMed ID: 38334265
[TBL] [Abstract][Full Text] [Related]
32. Apoptosis and Paraptosis Induced by Disulfiram-Loaded Ca
Guo Z; Gao X; Lu J; Li Y; Jin Z; Fahad A; Pambe NU; Ejima H; Sun X; Wang X; Xie W; Zhang G; Zhao L
ACS Nano; 2024 Mar; 18(9):6975-6989. PubMed ID: 38377439
[TBL] [Abstract][Full Text] [Related]
33. Cannabidiol-induced activation of the metallothionein pathway impedes anticancer effects of disulfiram and its metabolite CuET.
Buchtova T; Skrott Z; Chroma K; Rehulka J; Dzubak P; Hajduch M; Lukac D; Arampatzis S; Bartek J; Mistrik M
Mol Oncol; 2022 Apr; 16(7):1541-1554. PubMed ID: 34632694
[TBL] [Abstract][Full Text] [Related]
34.
Hou L; Liu Y; Liu W; Balash M; Zhang H; Zhang Y; Zhang H; Zhang Z
Acta Pharm Sin B; 2021 Jul; 11(7):2016-2030. PubMed ID: 34386335
[TBL] [Abstract][Full Text] [Related]
35. Silk Fibroin-Modified Disulfiram/Zinc Oxide Nanocomposites for pH Triggered Release of Zn
Zhao YZ; Lin MT; Lan QH; Zhai YY; Xu HL; Xiao J; Kou L; Yao Q
Mol Pharm; 2020 Oct; 17(10):3857-3869. PubMed ID: 32833457
[TBL] [Abstract][Full Text] [Related]
36. Differential Cytotoxicity Mechanisms of Copper Complexed with Disulfiram in Oral Cancer Cells.
Chen SY; Chang YL; Liu ST; Chen GS; Lee SP; Huang SM
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33918312
[TBL] [Abstract][Full Text] [Related]
37. Enhanced localized therapeutic precision: A face-to-face folate-targeted Cu
Wang P; Liu B; Wang Q; Wang Y; Gao X; Gou J; He H; Zhang Y; Yin T; Jin X; Tang X
Int J Pharm; 2024 Jun; 658():124213. PubMed ID: 38729382
[TBL] [Abstract][Full Text] [Related]
38. Enzyme-triggered on-demand release of a H
Zhang S; Hussain S; Tang Y; Wang K; Wang X; Zhang L; Liao Y; Wang C; Hao Y; Gao R
J Mater Chem B; 2024 Apr; 12(14):3404-3416. PubMed ID: 38487992
[TBL] [Abstract][Full Text] [Related]
39. Disulfiram: A Food and Drug Administration-approved multifunctional role in synergistically drug delivery systems for tumor treatment.
Xu L; Sun Y; Li Y; Sun J; Guo Y; Shen Q; Wei Q; Shen JW
Int J Pharm; 2022 Oct; 626():122130. PubMed ID: 36007849
[TBL] [Abstract][Full Text] [Related]
40. Disulfiram-gold-nanorod integrate for effective tumor targeting and photothermal-chemical synergistic therapy.
Xu C; Zhang T; Lu G; Chen K; Tao J; Zhang Y; Teng Z; Yang B
Biomater Sci; 2020 Jun; 8(12):3310-3319. PubMed ID: 32400782
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
